Results 21 to 30 of about 445,510 (263)

The Effect of Type 2 Diabetes Mellitus on the Prognosis of Patients with Dilated Cardiomyopathy [PDF]

Zhongguo quanke yixue, 2023
Background Type 2 diabetes mellitus increases the risk of early onset of cardiovascular disease in patients, which poses a major threat to human health. Exploring the impact of type 2 diabetes mellitus on prognosis of patients with dilated cardiomyopathy
WANG Haiyan, HUANG Yuan, GUI Chun
doaj   +1 more source

An Evidence-based Assessment of Genes in Dilated Cardiomyopathy

medRxiv, 2020
Background: The cardiomyopathies are classically categorized as hypertrophic (HCM), dilated (DCM), and arrhythmogenic right ventricular (ARVC), and each have a signature genetic theme.
Elizabeth Jordan, Laiken Peterson, Tomohiko Ai, B. Asatryan, Lucas M. Bronicki, E. Brown, R. Celeghin, M. Edwards, J. Fan, J. Ingles, C. James, O. Jarinova, Renee Johnson, D. Judge, N. Lahrouchi, Ronald H. Lekanne Deprez, R. Lumbers, F. Mazzarotto, A. M. Domingo, Rebecca L. Miller, A. Morales, B. Murray, S. Peters, K. Pilichou, A. Protonotarios, C. Semsarian, P. Shah, P. Syrris, C. Thaxton, J. V. van Tintelen, R. Walsh, Jessica J Wang, J. Ware, R. E. Hershberger   +33 more
semanticscholar   +1 more source

The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta‐analysis

Clinical Cardiology, Volume 45, Issue 12, Page 1163-1170, December 2022., 2022
Abstract The implantable cardiac defibrillator (ICD) is common for the management of nonischemic cardiomyopathy (NICM). Mortality is a crucial issue for patients with NICM. We can understand the mortality events of ICD versus medicine treatment via a systemic review and meta‐analysis of randomized clinical trials.
Wenfeng He, Cheng Xue, Jiankang Zheng, Zhuang Shuai   +3 more
wiley   +1 more source

Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Dilated cardiomyopathy (DCM) is genetically heterogeneous, with >100 purported disease genes tested in clinical laboratories.
F. Mazzarotto, U. Tayal, R. Buchan, W. Midwinter, Alicja E Wilk, N. Whiffin, R. Govind, Erica Mazaika, A. de Marvao, T. Dawes, L. Felkin, Mian Ahmad, P. Theotokis, Elizabeth C. Edwards, Alexander Y. Ing, K. Thomson, L. Chan, D. Sim, A. Baksi, A. Pantazis, Angharad M. Roberts, H. Watkins, B. Funke, D. O’Regan, I. Olivotto, P. J. Barton, Sanjay K. Prasad, S. Cook, J. Ware, R. Walsh   +29 more
semanticscholar   +1 more source

Dilated cardiomyopathy and aldosteronoma: a causal link?

ESC Heart Failure, 2020
The aim of this study is to reveal the causal relationship between dilated cardiomyopathy and aldosteronoma. A 44‐year‐old male dilated cardiomyopathy patient with aldosteronoma, who demonstrated a worse cardiac function after 1 year therapy with ...
Jiyu Zhang, Jin Yang, Yueliang Li
doaj   +1 more source

Cardiomyopathy, familial dilated [PDF]

Orphanet Journal of Rare Diseases, 2006
AbstractDilated cardiomyopathy (DCM) is a heart muscle disease characterized by ventricular dilatation and impaired systolic function. Patients with DCM suffer from heart failure, arrhythmia, and are at risk of premature death. DCM has a prevalence of one case out of 2500 individuals with an incidence of 7/100,000/year (but may be under diagnosed).
Matthew R.G. Taylor, Luisa Mestroni, Elisa Carniel   +2 more
openaire   +4 more sources

BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy

Protein & Cell, 2020
Dysregulation of circadian rhythms associates with cardiovascular disorders. It is known that deletion of the core circadian gene Bmal1 in mice causes dilated cardiomyopathy.
Ermin Li, Xiuya Li, Jie Huang, Chen Xu, Qianqian Liang, Kehan Ren, Aobing Bai, Chao Lu, R. Qian, N. Sun   +9 more
semanticscholar   +1 more source

Collagen content, but not the ratios of collagen type III/I mRNAs, differs among hypertensive, alcoholic, and idiopathic dilated cardiomyopathy

Brazilian Journal of Medical and Biological Research, 2008
Cardiac interstitial fibrosis may contribute to ventricular dysfunction and the prognosis of patients with dilated cardiomyopathy. The objective of the present study was to determine if total myocardial collagen content and collagen type III/I (III/I ...
H.N. Soufen, V.M.C. Salemi, I.M.S. Aneas, F.J.A. Ramires, A.M.D. Benício, L.A. Benvenuti, J.E. Krieger, C. Mady   +7 more
doaj   +1 more source

Familial dilated cardiomyopathy [PDF]

Heart, 1994
ardiomyopathies are diseasesof the heart muscle that renderthe heart unable to properlypump enough blood to the body. In thedilated form of cardiomyopathy(called dilated cardiomyopathy orDCM), the heart is enlarged (Figure 1).As the heart enlarges, it becomes lesseffective in pumping blood, whichthen leads to symptoms of heart failureand irregular ...
L. Mestroni, M. Krajinovic, G. M. Severini, B. Pinamonti, A. D. Lenarda, GIACCA, MAURO, A. Falaschi, F. Camerini   +7 more
openaire   +4 more sources

Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy

Circulation Cardiovascular Imaging, 2020
Supplemental Digital Content is available in the text. Background: Dilated cardiomyopathy is associated with increased risk of major cardiovascular events.
A. Alba, J. Gaztanaga, F. Foroutan, P. Thavendiranathan, M. Merlo, David Alonso-Rodríguez, Víctor Vallejo-García, R. Vidal-Pérez, C. Corros-Vicente, M. Barreiro-Pérez, P. Pazos-López, E. Pérez-David, S. Dykstra, J. Flewitt, J. Pérez-Rivera, María Vázquez-Caamaño, S. Katz, G. Sinagra, L. Køber, J. Poole, H. Ross, M. Farkouh, James A. White   +22 more
semanticscholar   +1 more source